Crossmark

The role of budget impact and its relationship with cost-effectiveness in reimbursement decisions on health technologies in the Netherlands

Published Online: 2024-02-27

Published Print: 2024-11

Authors

Reckers-Droog, Vivian http://orcid.org/0000-0001-8722-3431
Enzing, Joost

Brouwer, Werner
Funding

Funding for this research was provided by:

AstraZeneca

Roche
License Information

Text and Data Mining valid from 2024-02-27

Version of Record valid from 2024-02-27
More Information

Article History

Received: 2 October 2023

Accepted: 18 January 2024

First Online: 27 February 2024

Declarations

:

: Dr Reckers-Droog reports grants from Roche and AstraZeneca, during the conduct of the study. Dr. Enzing reports no conflicts of interest. Dr Brouwer reports grants from Roche and AstraZeneca, during the conduct of the study. Dr Brouwer reports being member of the Scientific Advisory Board (WAR) of the National Health Care Institute. No other conflicts of interest are reported.

: Not required.

Document is current